Moderna plans to test booster doses of variant-specific vaccine for NIH study
CNBC's Meg Tirrell reports that Modena has shipped doses of its variant-specific vaccine to the National Institutes of Health for a clinical study, and the company has also boosted its manufacturing targets for the vaccine.
UP NEXT
UP NEXT
-
Dough CEO: Netflix has 'fallen out of favor' with younger investors
CNBC
-
Interactive Brokers chairman discusses pop on earnings
CNBC
-
Netflix beats Q1 EPS $3.75 vs. $2.97 estimated
CNBC
-
CSX EPS misses $0.93 vs. $0.95 estimated
CNBC
-
CFRA research analyst discusses Netflix Q1 earnings
CNBC
-
CNBC's Alex Sherman and NYT Ed Lee discuss Netflix earnings
CNBC
-
Verdict reached in Derek Chauvin murder trial
CNBC
-
Citi CEO Jane Fraser on exiting 13 retail markets outside of US
CNBC
-
What we've learned about online learning with Khan Academy CEO
CNBC
-
The $100M company that only owns a New Jersey deli with $35,000 in sales over the last two years
CNBC
-
Phillip Morris CEO says it's premature to pronounce the company will enter the cannabis business
CNBC
-
Bill Miller: We sold GameStop earlier this year
CNBC
-
Athleta CEO on expanding to Canada and company's goal to double athleisure sales
CNBC
-
Pot stocks surge as federal legalization looms
CNBC
-
Two market pros how to play the reopening trade
CNBC
-
What's Apple's new product reveal means for the stock
CNBC